Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for AbCellera Biologics (ABCL): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
9 analysts
Options Flow (P/C)
—
Avg Consensus PT
$13
+14.6%
Highest Price Target
$30
+164.6%
Lowest Price Target
$4
-64.7%
Short Interest
16.3%
Declining — Bullish
Insider Activity (30d)
Net Buyer
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Truist Securities | Robyn Kamaus— | +164.6% | $12 → $30 | Maintained | Buy |
| Aug 6, 2026 | Stifel | Stephen Willey— | -20.6% | $8 → $9 | Maintained | Buy |